RENBP and infection: - 0.5%) below which transmission can be considered to be interrupted.[24] It has also been shown by other studies [[25], [26], [27]] that molecular xenomonitoring can be used for monitoring recrudescence of infection in post-MDA and validation phases when the infection is at a level lower than that detectable by Ag or microfilaria testing.